Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28K Hold
191
– – ﹤0.01% 146
2026
Q1
$28.1K Sell
191
-12
-6% -$1.95K ﹤0.01% 151
2025
Q4
$39.6K Sell
203
-214
-51% -$51K ﹤0.01% 173
2025
Q3
$117K Sell
417
-237
-36% -$60.4K ﹤0.01% 138
2025
Q2
$143K Hold
654
– – ﹤0.01% 131
2025
Q1
$91.4K Hold
654
– – ﹤0.01% 142
2024
Q4
$109K Buy
654
+30
+5% +$5.33K ﹤0.01% 153
2024
Q3
$106K Buy
624
+53
+9% +$7.68K ﹤0.01% 156
2024
Q2
$80.6K Sell
571
-106
-16% -$13.2K ﹤0.01% 160
2024
Q1
$85K Buy
677
+223
+49% +$25.5K ﹤0.01% 162
2023
Q4
$47.9K Buy
+454
New +$49.5K ﹤0.01% 157

Other funds holding ORCL

Bellevue Group's ORCL Position: Q2 2026 in Review

Bellevue Group held its Oracle (ORCL) position steady in Q2 2026 at 191 shares worth $28K. The position accounts for ﹤0.01% of the portfolio, ranked #146.

Bellevue Group first reported a position in ORCL in Q4 2023 and has held it in 11 quarters since. The position peaked at $143K in Q2 2025. 3,537 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Bellevue Group held 191 shares of Oracle worth $28K as of Q2 2026.
  • Bellevue Group left its Oracle share count unchanged in Q2 2026.
  • Oracle made up ﹤0.01% of Bellevue Group's portfolio in Q2 2026, its #146 holding.
  • Bellevue Group first reported a position in Oracle in Q4 2023 and has held it in 11 quarters since.
  • Bellevue Group's Oracle position peaked at $143K in Q2 2025.
  • 3,537 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Bellevue Group's 13F filing for Q2 2026, filed 14 Aug 2026.